| Sanofi-Aventis (Suisse) SA - Clexane 150 mg/ml, solution injectable |
| 49456 | | 08 | | Clexane 150 mg/ml | | solution injectable | | B01AB05 | | Enoxaparin | | 28.12.1999 | | |
|
| Composition |
| enoxaparinum natricum 150 mg corresp. 15000 U.I. anti-Xa, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Enoxaparine Sodique | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Enoxaparine Sodique | 150 mg |
| | | | Agents auxilliaires |
|---|
| Anti-Xa |
| |
|
|
